Filter by: patients
Home > Community Treatment Reports and Side Effects > Meloxicam Treatment Report
What is Meloxicam?

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of osteoarthritis and rheumatoid arthritis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Pain 191 48 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Fibromyalgia 156 39 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Inflammation 126 28 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 33 6 Efficacy_moderate Efficacy_slight Efficacy_none
Pain, Inflamation, muscle spasms 33 14 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Arthritis pain 31 10 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none

See all 568 patients currently taking Meloxicam

Mouse over the table for more information

Reported Dosages

Frequently reported dosages based on patients currently taking Meloxicam. See all 17 dosages ►

  15mg as needed daily 7.5mg/5mL as needed 7.5mg as needed 30 mg weekly 7.5 mg/5 mL daily 7.5 mg daily 2 x 7.5 mg/5 mL daily 15 mg daily 30 mg daily
  19 Number of Patients: 19 2 Number of Patients: 2 5 Number of Patients: 5 17 Number of Patients: 17 1 Number of Patients: 1 42 Number of Patients: 42 86 Number of Patients: 86 27 Number of Patients: 27 363 Number of Patients: 363 17 Number of Patients: 17  

Reported Stop Reasons

Why Patients Stopped Taking Meloxicam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 52   Did not seem to work: 36%
Side effects too severe 36   Side effects too severe: 25%
Doctor's advice 35   Doctor's advice: 24%
Other 26   Other: 18%
Course of treatment ended 12   Course of treatment ended: 8%
Personal research 6   Personal research: 4%
Expense 5   Expense: 3%
Change in health plan coverage 5   Change in health plan coverage: 3%
Not indicated 5   Not indicated: 3%

See all 145 patients who’ve stopped taking Meloxicam

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Meloxicam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Meloxicam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Meloxicam

Always
 127 77%
Usually
 18 11%
Sometimes
 12 7%
Never
 7 4%

Burden

Difficulty being on treatment

Burden of Meloxicam

Very
 10 6%
Somewhat
 4 2%
A little
 18 11%
Not at all
 132 80%

Cost

Paid out of pocket

Cost of Meloxicam

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 1%
$25-49
 9 9%
< $25
 88 90%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.